In one of the pioneering genetic studies of acne, it has been seen that the condition that affects millions of teenagers and adults could have a genetic basis. This genetic study can also pave the way for new and accurate treatment for acne promise researchers.
All news from Dermatology
2014, Shoe giant Nike began developing a shoe for elite marathon runners to help them run a marathon in under two hours.
Cresco Labs one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has been granted the first approval to operate a marijuana dispensary in the state of Ohio.
Host genetic factors such as MBL2 gene polymorphisms cause defects in the polymerization of MBL protein and result in a functional deficiency and or in low serum levels that can influence susceptibility to various viral infections.
A 40-mg dose of slow-release morphine may be safe for non-severely obese patients with obstructive sleep apnea (OSA), researchers in Australia report.
Anxiety during the preoperative period is the most common problem with many postoperative complications such as an increase in postoperative pain, delay of healing and prolong the hospital stay.
Idiopathic scoliosis (IS) is a complex genetic disorder that affects approximately 4% of children worldwide, yet its underlying biological cause remains unknown. Researchers at The Hospital for Sick Children (SickKids) have determined that neuroinflammatory signals, the signals that trigger inflammation in the spinal cord, drive spinal curve formation in zebrafish.
The Next-Generation Copy Number Alteration (NG-CNA) assay can analyze small amounts of material to estimate metastatic risk, reports The Journal of Molecular Diagnostics
For men newly diagnosed with prostate cancer or patients previously treated, the risk of metastasis is a crucial determinant of whether to choose conservative management or undergo further treatment.
A Canadian clinical trial published in the New England Journal of Medicine provides the first approach for safely preventing blood clots (or venous thromboembolism) in people with cancer.